Digital transformation in the Indian Pharmaceutical sector is not new, it has started a decade ago.
With full-fledged vaccination administration in the process and with a self-sufficient agenda for redefining the business model, it becomes important for India to reevaluate its current role in the global pharmaceutical market.
We were privileged to have the stalwarts from the pharma sector, Lion Daara B Patel, secretary-General of the Indian Drug Manufacturers’ Association (IDMA), Salil S. Kallianpur, founder and MD of ARKS Knowledge Consulting Pvt.
and Dinesh Chindarkar, Co-founder of MediaMedic Communications.Harnessing the technology for providing a tailored solutionDuring the pandemic, the pharmaceutical sector has re-focussed its in-person dealings to virtual.
“By deploying machine learning analytics, HCPs treat mental ailments based on tracking, correlating, and scoring three factors – cognitive function, clinical symptoms, and brain activity.”As the Indian Pharmaceutical industry grabs digital transformation, scenarios accompanied by increased usage of advanced technology will see a rise in precision medicine in the next few years.
According to Salil, “the concept of time and distance has gone away” as we are going through digital transformation.